MedTrace Logo

Microbiology in Obstructive BIliary Disease

NCT05464693 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2022-07-21

No results posted yet for this study

Summary

Patients admitted to hospital due to obstructive biliary disease secondary to benign and malign etiologies, undergoing ERCP, will be selected. Bile sample will be taken in ERCP procedure with sterile technique. Its macroscopic appearance will be assessed and biliary culture will be performed.

Conditions

  • Biliary Disease

Interventions

DIAGNOSTIC_TEST

ERCP biliary culture

The sample of biliary aspirate will be assessed as follows. 1. Its macroscopic appearance will be analyzed: yellow, black, or purulent. 2. Biliary culture will be performed; if bacterial growth is observed, its identification will be carried out by means of MALDI-TOF MS mass spectrometry and antibiotic susceptibility tests will be carried out, using the automated VITEK system.

Sponsors & Collaborators

  • Hospital Universitario Dr. Jose E. Gonzalez

    lead OTHER

Principal Investigators

  • Joel Omar Jáquez Quintana · Hospital Universitario Dr. Jose E. Gonzalez

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-24
Primary Completion
2022-08-30
Completion
2022-08-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05464693 on ClinicalTrials.gov